Author

M. Anwer

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential

Together, these advances position engineered superantigens as promising immune‐amplifying platforms with the potential to complement existing cancer immunotherapies and improve responses in poorly immunogenic tumors.

U. Y. Virk, H. A. Malik, M. Anwer et al. · The FASEB Journal · 0 citations

Review Open access Aug 2026

Cancer immunotherapy under immune pressure: Mechanisms of resistance and the shift toward precision immune engineering.

Cancer immunotherapy has transformed the treatment landscape across multiple malignancies; however, durable responses remain limited to a subset of patients due to the emergence of intrinsic and acquired resistance. Increasing evidence suggests that therapeutic immune pressure itself acts as a selective force that shap...

M. Anwer · International Immunopharmaco... · 0 citations

#artificial intelligence Review Open access Sep 2026

Decoding cancer with artificial intelligence: Transforming research, diagnosis, and therapy with future insights

Emerging AI paradigms offer future-ready frameworks for personalized, privacy-preserving oncology care and multi-omics integration powered by AI enables the discovery of robust biomarkers for diagnosis, prognosis, and therapy response prediction.

M. Anwer, Krupa R. Bhaliya, Ming Q. Wei · Translational Oncology · 0 citations